| Revenue growth | FY26 revenue grew 22% YoY; Q4 revenue grew 15%. |
|---|---|
| Margins | EBITDA margins maintained above 25%; targeting 20%+ sustainably. |
| Demand visibility | Strong traction in fragrance and flavor ingredients globally. |
| Management confidence | Highly optimistic, emphasizing 'beyond 5k' long-term revenue vision. |
Growth
FY26 revenue rose 21.7% to ₹2,583cr, while PAT surged 75% due to improved product mix and operating leverage.
Outlook
Targeting ₹5,000cr revenue and ₹1,000cr+ EBITDA within 3-4 years; Phase 1 capex completes June 2026.
Risks
Raw material volatility (pine-based) and global logistics delays remain key external sensitivities.
Earnings Call filed with NSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,594.10
- Market cap
- ₹14,040 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 40.1×Sector 37.5×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
- Call
- Guides 100% growth
Privi Speciality Chemicals Investor Presentation: Key Takeaways
Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.
- Call
- Guides 100% growth
Privi Speciality Chemicals Q1 FY27 Results: Net Profit ₹82.8 Cr, Up 43.7% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹666.2 Cr (+19.2% YoY) and net profit of ₹82.8 Cr (+43.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹82.8 Cr · +43.7% YoY
Privi Speciality Chemicals Earnings Call: Key Takeaways
Privi reported strong FY26 performance with 22% revenue growth and 25.76% EBITDA margins, driven by volume growth and improved product mix.